Glioma Diagnosis and TreatmentAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentSarcoma Diagnosis and TreatmentDrug-Induced Adverse Reactions
Publications
62
Citations
459
Est. group size
—
Recurring co-author estimate
Active years
176
Publishing since 1850
Publication cadence
Publications per year over the last 10 years — averaging 3.0/year recently
Recent publications
- Karyotypic clonal fraction predicts adverse outcome in <i>TP53</i> -mutated myeloid neoplasms: an International <i>TP53</i> investigators Network (iTiN) study
Journal of Clinical Pathology · 2025
- 1272 A 4-Gene Co-Alteration Signature (SIG4) Predictive of Favorable Outcomes in High-Grade TP53 Mutated Myeloid Neoplasms: An International TP53 Investigators Network (iTIN) Study
Laboratory Investigation · 2025
- 1295 Prognostic Impact of Chromosome 7 Losses in High-Grade TP53 Mutated Myeloid Neoplasms
Laboratory Investigation · 2025
- 95 Epstein-Barr Virus Positive Inflammatory Follicular Dendritic Cell Tumor and Epstein-Barr Virus-Associated Smooth Muscle Tumor Exhibit Distinct Methylation Profiles
Laboratory Investigation · 2025
- Single Cell Transcriptomic Analysis of Spinal Ependymoma from a Patient with NF2-related Schwannomatosis Indicates a Radial-Glia to Ependymal Cell Developmental Hierarchy
2025
- Somatic co‐alteration signatures are prognostic in high‐grade <scp><i>TP53</i></scp>‐mutated myeloid neoplasms
British Journal of Haematology · 2024
- Long‐Term Effects of Lecanemab on Biomarkers of Neurodegeneration in Plasma
Alzheimer s & Dementia · 2024
- Amyloid Plaque Reduction as a Surrogate Marker of Efficacy: Assessment of Amyloid PET and Change in CDR‐SB Utilizing Semi‐Mechanistic Model
Alzheimer s & Dementia · 2024
- Novel CRTC1::MRTFB(MKL2) Gene Fusion Detected in Myxoid Mesenchymal Neoplasms With Myogenic Differentiation Involving Bone and Soft Tissues
Modern Pathology · 2024
- Spatial Transcriptomics of Spinal Ependymoma in NF2-related Schwannomatosis
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- EPCO-60. EXPRESSION OF EARLY PROGENITOR MARKERS WITHIN NF2-ASSOCIATED SPINAL EPENDYMOMA
Neuro-Oncology · 2024
- Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma
JCO Precision Oncology · 2023
- Inappropriate use of clinical practices in Canada: a systematic review
Canadian Medical Association Journal · 2022
- 21. Co-existence of two activating variants in somatic overgrowth & vascular anomalies: 7 years' findings at a single center
Cancer Genetics · 2022
- Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery
BMC Urology · 2021
Publishes in
- Laboratory Investigation×3
- Alzheimer s & Dementia×2
- Neuro-Oncology×2
- Canadian Medical Association Journal×1
- BMC Urology×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile